{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:50Z","timestamp":1790494130057,"version":"4.1.0"},"reference-count":184,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005886","name":"Pediatric Infectious Diseases Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00909","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T01:05:45Z","timestamp":1589850345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":133,"title":["Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines"],"prefix":"10.3389","volume":"11","author":[{"given":"Lynda","family":"Coughlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e008748","DOI":"10.1136\/bmjopen-2015-008748","article-title":"Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase","volume":"5","author":"Green","year":"2015","journal-title":"BMJ Open."},{"key":"B5","doi-asserted-by":"publisher","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1128\/jvi.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against Ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1128\/JVI.06969-11","article-title":"Overreliance on the hexon gene, leading to misclassification of human adenoviruses","volume":"86","author":"Singh","year":"2012","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.omtm.2019.12.003","article-title":"Targeting antigen to the surface of EVs improves the in vivo immunogenicity of human and non-human adenoviral vaccines in mice","volume":"16","author":"Bliss","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.celrep.2017.05.008","article-title":"An engineered virus library as a resource for the spectrum-wide exploration of virus and vector diversity","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J Gen Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/hgtb.2018.044","article-title":"Novel vector construction based on alternative adenovirus types via homologous recombination","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum Gene Ther Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1099\/jgv.0.000978","article-title":"Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56","volume":"99","author":"Duffy","year":"2018","journal-title":"J Gen Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/10430340460745838","article-title":"Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors","volume":"15","author":"Roy","year":"2004","journal-title":"Human Gene Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/v2081681","article-title":"Adenoviral producer cells","volume":"2","author":"Kovesdi","year":"2010","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","article-title":"Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study","volume":"20","author":"Liebowitz","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/vaccines6020029","article-title":"Clinical advances in viral-vectored influenza vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"Teigler","year":"2012","journal-title":"J Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/14760584.2019.1588113","article-title":"A review of 65 years of human adenovirus seroprevalence","volume":"18","author":"Mennechet","year":"2019","journal-title":"Expert Rev Vaccines."},{"key":"B31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.omtm.2018.07.007","article-title":"A bovine adenoviral vector-based H5N1 influenza -vaccine provides enhanced immunogenicity and protection at a significantly low dose","volume":"10","author":"Sayedahmed","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/viro.1996.0239","article-title":"A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier","volume":"219","author":"Xiang","year":"1996","journal-title":"Virology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1128\/jvi.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"300ra126","DOI":"10.1126\/scitranslmed.aac5745","article-title":"Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults","volume":"7","author":"Green","year":"2015","journal-title":"Sci Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","article-title":"Adenovirus-triggered innate signalling pathways","volume":"1","author":"Fejer","year":"2011","journal-title":"Eur J Microbiol Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1182\/blood-2010-03-272336","article-title":"CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells","volume":"117","author":"Bassett","year":"2011","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1096\/fasebj.13.15.2153","article-title":"Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo","volume":"13","author":"Jimenez-Chillaron","year":"1999","journal-title":"FASEB J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/eji.1830251239","article-title":"Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector","volume":"25","author":"Juillard","year":"1995","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","article-title":"Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity","volume":"188","author":"Johnson","year":"2012","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.4049\/jimmunol.0900537","article-title":"Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination","volume":"184","author":"Holst","year":"2010","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1099\/vir.0.81620-0","article-title":"Analysis of the interaction between RGD-expressing adenovirus type 5 fiber knob domains and alphavbeta3 integrin reveals distinct binding profiles and intracellular trafficking","volume":"87","author":"Lord","year":"2006","journal-title":"J Gen Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-e","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"12367","DOI":"10.1128\/JVI.01833-13","article-title":"A direct and versatile assay measuring membrane penetration of adenovirus in single cells","volume":"87","author":"Suomalainen","year":"2013","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chom.2011.07.006","article-title":"Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure","volume":"10","author":"Burckhardt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0092-8674(93)90382-z","article-title":"Stepwise dismantling of adenovirus 2 during entry into cells","volume":"75","author":"Greber","year":"1993","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/j.1460-2075.1993.tb05919.x","article-title":"Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy","volume":"12","author":"Stewart","year":"1993","journal-title":"EMBO J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1000808","DOI":"10.1371\/journal.ppat.1000808","article-title":"A capsid-encoded PPxY-motif facilitates adenovirus entry","volume":"6","author":"Wodrich","year":"2010","journal-title":"PLoS Pathog"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.1128\/JVI.01428-12","article-title":"Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape","volume":"86","author":"Maier","year":"2012","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1128\/JVI.79.12.7503-7513.2005","article-title":"Localization of regions in CD46 that interact with adenovirus","volume":"79","author":"Gaggar","year":"2005","journal-title":"J Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1128\/jvi.78.9.4454-4462.2004","article-title":"The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3","volume":"78","author":"Sirena","year":"2004","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"eaax3567","DOI":"10.1126\/sciadv.aax3567","article-title":"Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor","volume":"5","author":"Baker","year":"2019","journal-title":"Sci Adv"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1128\/jvi.77.6.3712-3723.2003","article-title":"The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses","volume":"77","author":"Shayakhmetov","year":"2003","journal-title":"J Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/JVI.01926-06","article-title":"Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses","volume":"81","author":"Iacobelli-Martinez","year":"2007","journal-title":"J Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e00670-17","DOI":"10.1128\/mBio.00670-17","article-title":"Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages","volume":"8","author":"Maler","year":"2017","journal-title":"mBio"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1128\/jvi.78.10.5368-5381.2004","article-title":"Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors","volume":"78","author":"Shayakhmetov","year":"2004","journal-title":"J Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/mthe.2000.0227","article-title":"Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver","volume":"3","author":"Tao","year":"2001","journal-title":"Mol Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.4049\/jimmunol.178.4.2440","article-title":"PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection","volume":"178","author":"Carey","year":"2007","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1089\/hum.1997.8.14-1675","article-title":"Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract","volume":"8","author":"Worgall","year":"1997","journal-title":"Human Gene Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1006914","DOI":"10.1371\/journal.ppat.1006914","article-title":"Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor","volume":"14","author":"Stichling","year":"2018","journal-title":"PLoS pathog"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.1128\/jvi.74.20.9655-9667.2000","article-title":"Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection","volume":"74","author":"Zsengeller","year":"2000","journal-title":"J Virol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1089\/104303403322542275","article-title":"A hemodynamic response to intravenous adenovirus vector particles is caused by systemic kupffer cell-mediated activation of endothelial cells","volume":"14","author":"Schiedner","year":"2003","journal-title":"Human Gene Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"14622","DOI":"10.1128\/JVI.79.23.14622-14631.2005","article-title":"Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1","volume":"79","author":"Cotter","year":"2005","journal-title":"J Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.4049\/jimmunol.0804269","article-title":"Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response","volume":"182","author":"Zaiss","year":"2009","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1021\/mp8000974","article-title":"Scavenger receptor A: a new route for adenovirus 5","volume":"6","author":"Haisma","year":"2009","journal-title":"Mol Pharm"},{"key":"B75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nri3515","article-title":"Scavenger receptors in homeostasis and immunity","volume":"13","author":"Canton","year":"2013","journal-title":"Nat Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"Khare","year":"2012","journal-title":"J Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo","volume":"31","author":"Di Paolo","year":"2009","journal-title":"Immunity"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J Gen Virol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2004.03.004","article-title":"Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor","volume":"97","author":"Furumoto","year":"2004","journal-title":"J Control Rel"},{"key":"B80","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.4049\/jimmunol.177.9.6018","article-title":"Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells","volume":"177","author":"Dolan","year":"2006","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/ni854","article-title":"Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes","volume":"3","author":"Thery","year":"2002","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Thery","year":"2009","journal-title":"Nat Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4049\/jimmunol.165.3.1259","article-title":"Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface","volume":"165","author":"Denzer","year":"2000","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4049\/jimmunol.179.3.1489","article-title":"CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo","volume":"179","author":"Segura","year":"2007","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/471581a","article-title":"Immunology: cross-dressers turn on T cells","volume":"471","author":"Yewdell","year":"2011","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1128\/jvi.76.6.2899-2911.2002","article-title":"Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product","volume":"76","author":"Mercier","year":"2002","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/mthe.2002.0538","article-title":"Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells","volume":"5","author":"Korst","year":"2002","journal-title":"Mol Ther"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1128\/jvi.74.20.9617-9628.2000","article-title":"Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway","volume":"74","author":"Morelli","year":"2000","journal-title":"J Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"37175","DOI":"10.1074\/jbc.M303496200","article-title":"The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain","volume":"278","author":"Molinier-Frenkel","year":"2003","journal-title":"J Biol Chem"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"8169","DOI":"10.1158\/1078-0432.CCR-08-1474","article-title":"Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule","volume":"14","author":"Johnson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","article-title":"Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule","volume":"9","author":"Pereboev","year":"2004","journal-title":"Mol Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4161\/cbt.4.3.1499","article-title":"High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN","volume":"4","author":"Korokhov","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1099\/vir.0.008342-0","article-title":"Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin DC-SIGN","volume":"90","author":"Adams","year":"2009","journal-title":"J Gen Virol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4049\/jimmunol.179.3.1721","article-title":"Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses","volume":"179","author":"Lore","year":"2007","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/sj.mt.6300078","article-title":"A CD46-binding chimpanzee adenovirus vector as a vaccine carrier","volume":"15","author":"Tatsis","year":"2007","journal-title":"Mol Ther"},{"key":"B98","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.virol.2004.02.016","article-title":"Adenovirus serotype 3 utilizes CD80 (B7","volume":"322","author":"Short","year":"2004","journal-title":". Virology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/vaccines6030042","article-title":"Improved induction of anti-melanoma t cells by adenovirus-5\/3 fiber modification to target human DCs","volume":"6","author":"Chondronasiou","year":"2018","journal-title":"Vaccines"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0125851","DOI":"10.1371\/journal.pone.0125851","article-title":"Incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy","volume":"10","author":"Wilkinson-Ryan","year":"2015","journal-title":"PLoS ONE."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2004.11.014","article-title":"In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity","volume":"332","author":"Hsu","year":"2005","journal-title":"Virology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/14760584.2017.1394842","article-title":"Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane","volume":"16","author":"Vitelli","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2010.519332","article-title":"Production of adenovirus vectors and their use as a delivery system for influenza vaccines","volume":"10","author":"Vemula","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpb.2018.06.001","article-title":"Stability and suitability for storage and distribution of Ad26","volume":"129","author":"Capelle","year":"2018","journal-title":". Eur J Pharm Biopharm"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.vaccine.2017.04.026","article-title":"Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo","volume":"35","author":"Afkhami","year":"2017","journal-title":"Vaccine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci Transl Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e0006870","DOI":"10.1371\/journal.pntd.0006870","article-title":"A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis","volume":"12","author":"Wang","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","volume":"67","author":"Coughlan","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors","volume":"85","author":"Rhee","year":"2011","journal-title":"J Virol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J Virol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","article-title":"Adenovirus sensing by the immune system","volume":"21","author":"Atasheva","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000207194","article-title":"TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses","volume":"1","author":"Appledorn","year":"2009","journal-title":"J Innate Immun"},{"key":"B115","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1128\/JVI.02702-13","article-title":"Adenovirus detection by the cGAS\/STING\/TBK1 DNA sensing cascade","volume":"88","author":"Lam","year":"2014","journal-title":"J Virol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1128\/JVI.00500-16","article-title":"Diminished innate antiviral response to adenovirus vectors in cGAS\/STING-deficient mice minimally impacts adaptive immunity","volume":"90","author":"Anghelina","year":"2016","journal-title":"J Virol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Human Gene Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"Hensley","year":"2007","journal-title":"Mol Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1128\/JVI.00593-09","article-title":"Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus","volume":"83","author":"Finn","year":"2009","journal-title":"J Virol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4049\/jimmunol.176.1.200","article-title":"The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity","volume":"176","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"16756","DOI":"10.1038\/srep16756","article-title":"Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice","volume":"5","author":"Dicks","year":"2015","journal-title":"Sci Rep"},{"key":"B124","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.4049\/jimmunol.178.9.5802","article-title":"Antigen presentation by nonhemopoietic cells amplifies clonal expansion of effector CD8 T cells in a pathogen-specific manner","volume":"178","author":"Thomas","year":"2007","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1128\/IAI.00954-07","article-title":"Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells","volume":"75","author":"Dzierszinski","year":"2007","journal-title":"Infect Immun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1128\/JVI.02563-09","article-title":"Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes","volume":"84","author":"Kaufman","year":"2010","journal-title":"J Virol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1089\/hum.2011.218","article-title":"Combined fiber modifications both to target alpha(v)beta(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5","volume":"23","author":"Coughlan","year":"2012","journal-title":"Human Gene Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5","volume":"116","author":"Alba","year":"2010","journal-title":"Vectors Blood"},{"key":"B131","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J Virol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell."},{"key":"B133","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2012.05.025","article-title":"Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses","volume":"164","author":"Bradshaw","year":"2012","journal-title":"J Control Rel."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","article-title":"Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X","volume":"6","author":"Bradshaw","year":"2010","journal-title":"PLoS Pathog"},{"key":"B135","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett"},{"key":"B136","doi-asserted-by":"publisher","first-page":"112746","DOI":"10.1016\/j.jim.2020.112746","article-title":"Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations","volume":"479","author":"Havenar-Daughton","year":"2020","journal-title":"J Immunol Methods"},{"key":"B137","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ymthe.2005.09.018","article-title":"Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia","volume":"13","author":"Grinshtein","year":"2006","journal-title":"Mol Ther"},{"key":"B138","unstructured":"Harnessing the potential of adenovirus vectored vaccines\n            HolstP\n            ThomsenA\n          Viral Gene Therapy.2011"},{"key":"B139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e0220196","DOI":"10.1371\/journal.pone.0220196","article-title":"Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike Protein of Middle East respiratory syndrome coronavirus","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE"},{"key":"B141","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1080\/22221751.2019.1620083","article-title":"Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection","volume":"8","author":"Jia","year":"2019","journal-title":"Emerg. Microbes Infect"},{"key":"B142","doi-asserted-by":"publisher","first-page":"128","DOI":"10.15761\/GVI.1000128","article-title":"Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses","volume":"3","author":"Matchett","year":"2018","journal-title":"Glob Vaccines Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.vaccine.2016.12.008","article-title":"Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques","volume":"35","author":"Bolton","year":"2017","journal-title":"Vaccine"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/mi.2015.29","article-title":"Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection","volume":"8","author":"Jeyanathan","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.vaccine.2010.12.087","article-title":"Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF","volume":"29","author":"Krause","year":"2011","journal-title":"Vaccine"},{"key":"B146","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1128\/jvi.76.1.127-135.2002","article-title":"Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response","volume":"76","author":"Molinier-Frenkel","year":"2002","journal-title":"J Virol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"11241","DOI":"10.1128\/JVI.00721-06","article-title":"Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells","volume":"80","author":"Tamanini","year":"2006","journal-title":"J Virol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"11627","DOI":"10.1128\/JVI.79.18.11627-11637.2005","article-title":"Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation","volume":"79","author":"Schoggins","year":"2005","journal-title":"J Virol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s002510050447","article-title":"Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1","volume":"48","author":"Miwa","year":"1998","journal-title":"Immunogenetics"},{"key":"B150","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1128\/JVI.79.22.14161-14168.2005","article-title":"Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys","volume":"79","author":"Nanda","year":"2005","journal-title":"J Virol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.virol.2017.12.016","article-title":"Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding","volume":"515","author":"Nidetz","year":"2018","journal-title":"Virology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1016\/j.vaccine.2010.06.050","article-title":"Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28","volume":"28","author":"Kahl","year":"2010","journal-title":"Vaccine."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1128\/jvi.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Tibbles","year":"2002","journal-title":"J Virol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14760584.2020.1711054","article-title":"The potential of adenoviral vaccine vectors with altered antigen presentation capabilities","volume":"19","author":"Neukirch","year":"2020","journal-title":"Expert Rev Vaccines."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1099\/vir.0.82727-0","article-title":"Rapid and sustained CD4(+) T-cell-independent immunity from adenovirus-encoded vaccine antigens","volume":"88","author":"Holst","year":"2007","journal-title":"J Gen Virol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"Mikkelsen","year":"2011","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e100538","DOI":"10.1371\/journal.pone.0100538","article-title":"Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain","volume":"9","author":"Spencer","year":"2014","journal-title":"PLoS ONE"},{"key":"B158","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.4049\/jimmunol.1301290","article-title":"Adenovirus-based vaccine against listeria monocytogenes: extending the concept of invariant chain linkage","volume":"191","author":"Jensen","year":"2013","journal-title":"J Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"15020","DOI":"10.1038\/s41598-018-33375-1","article-title":"Development of a molecular adjuvant to enhance antigen-specific CD8(+) T cell responses","volume":"8","author":"Halbroth","year":"2018","journal-title":"Sci Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"Priddy","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1084\/jem.20081786","article-title":"Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells","volume":"205","author":"Perreau","year":"2008","journal-title":"J Exp Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B166","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O'Brien","year":"2009","journal-title":"Nat Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/infdis\/jis342","article-title":"Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)","volume":"206","author":"Duerr","year":"2012","journal-title":"J Infect Dis"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/JVI.80.4.1688-1699.2006","article-title":"A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques","volume":"80","author":"Capone","year":"2006","journal-title":"J Virol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/CVI.00144-09","article-title":"Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults","volume":"16","author":"Harro","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jinf.2019.02.003","article-title":"Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults","volume":"78","author":"Green","year":"2019","journal-title":"J Infect"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3389\/fimmu.2017.01551","article-title":"Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in Gambian infants and neonates: a randomized controlled trial","volume":"8","author":"Mensah","year":"2017","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ymthe.2016.11.003","article-title":"Viral Vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants","volume":"25","author":"Bliss","year":"2017","journal-title":"Mol Ther"},{"key":"B173","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1038\/s41598-018-21630-4","article-title":"Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP","volume":"8","author":"Bliss","year":"2018","journal-title":"Sci Rep"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/mt.2016.83","article-title":"Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants","volume":"24","author":"Afolabi","year":"2016","journal-title":"Mol Ther"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals","volume":"211","author":"Hodgson","year":"2015","journal-title":"J Infect Dis"},{"key":"B176","doi-asserted-by":"publisher","first-page":"286re285","DOI":"10.1126\/scitranslmed.aaa2373","article-title":"Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against plasmodium falciparum infection in Kenyan adults","volume":"7","author":"Ogwang","year":"2015","journal-title":"Sci Transl Med"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e0208328","DOI":"10.1371\/journal.pone.0208328","article-title":"First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children","volume":"13","author":"Tiono","year":"2018","journal-title":"PLoS ONE."},{"key":"B178","doi-asserted-by":"publisher","first-page":"e0192312","DOI":"10.1371\/journal.pone.0192312","article-title":"A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates","volume":"13","author":"Callendret","year":"2018","journal-title":"PLoS ONE"},{"key":"B179","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/infdis\/jiz070","article-title":"Safety and Immunogenicity of a 2-dose heterologous vaccination regimen with Ad26","volume":"220","author":"Anywaine","year":"2019","journal-title":"J Infect Dis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA."},{"key":"B181","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41541-019-0150-4","article-title":"Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations","volume":"4","author":"Salisch","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B182","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/infdis\/jis670","article-title":"First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)","volume":"207","author":"Baden","year":"2013","journal-title":"J Infect Dis"},{"key":"B183","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/infdis\/jis671","article-title":"Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)","volume":"207","author":"Barouch","year":"2013","journal-title":"J Infect Dis."},{"key":"B184","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T01:05:51Z","timestamp":1589850351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":184,"alternative-id":["10.3389\/fimmu.2020.00909"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00909","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"909"}}